EXAS earnings call for the period ending December 31, 2023.
This company hasn't performed well in the past 12 months.
These stocks can reward patient investors.
These 5 stocks from the maverick investor's flagship ARKK fund have gained a vote of confidence from analysts, with Wall Street predicting significant upside potential from current levels.
If the fund manager's calculations prove to be correct, shareholders could enjoy threefold returns over the coming four years. Is she right?
Both of these biotech stocks have been market-beaters over the prior 10 years. One stock, however, is a better buy right now.
If the fund manager's calculations prove to be correct, Tesla shareholders could enjoy sevenfold returns over the coming four years. Is she right?
Don't miss out on these potentially market-beating stocks.
EXAS earnings call for the period ending September 30, 2023.